Abstract
Background and Aims : Lipid oxidation leads to endothelial dysfunction and promotes foam cell formation during atherogenesis. Treatment with icosapent ethyl, a formulation of highly-purified omega-3 fatty acid (O3FA) EPA, reduced cardiovascular (CV) events in REDUCE-IT unlike trials using DHA-containing formulations in statin-treated patients. We compared the effects of EPA and DHA on lipid oxidation in membranes in combination with high-intensity statins.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
